| Literature DB >> 29021478 |
Harunobu Iida1, Hironari Hanaoka1, Yusa Asari1, Kana Ishimori1, Tomofumi Kiyokawa1, Yukiko Takakuwa1, Yoshioki Yamasaki1, Hidehiro Yamada1, Takahiro Okazaki1, Masatomo Doi2, Shoichi Ozaki1.
Abstract
Polyarteritis nodosa (PAN) is a medium vessel vasculitis affecting systemic organs. Muscle involvement of PAN usually lacks elevation of creatinine kinase (CK). We herein report a case of PAN with rhabdomyolysis. A 71-year-old man was hospitalized because of muscle weakness of the lower limbs that persisted for 1 month. On a physical examination, rapidly progressive lower proximal muscle weakness and bilateral drop foot were observed. His blood test showed an elevation in the C-reactive protein (19.5 mg/dL) and CK (13,435 IU/L) levels and negativity for anti-neutrophilic cytoplasmic antibody. Computed tomographic angiography showed stenosis of the left renal artery. Electromyogram indicated mono-neuritis multiplex pattern, and enhanced magnetic resonance imaging demonstrated discretely granular hyperintensities on T2 and slow tau inversion recovery in his femoral muscles. A femoral muscle-biopsy specimen showed fibrinoid necrosis of medium-sized vessels and disruption of the elastic lamina of the vessel wall in fascia. Furthermore, muscle necrosis was localized depending on the arterial distribution, suggesting ischemic changes in the muscles. Given these findings, he was diagnosed with PAN with rhabdomyolysis and treated with methyl-prednisolone pulse therapy followed by oral prednisolone at 50 mg/day. He was additionally treated with monthly intravenous cyclophosphamide at 500 mg. Sustained remission has been obtained for two months since the treatment. Although rhabdomyolysis rarely manifests with PAN, it should be included in a differential diagnosis of febrile patients presenting with acute myalgia and weakness with CK elevation.Entities:
Keywords: muscle involvement; polyarteritis nodosa; rhabdomyolysis
Mesh:
Substances:
Year: 2017 PMID: 29021478 PMCID: PMC5799066 DOI: 10.2169/internalmedicine.8913-17
Source DB: PubMed Journal: Intern Med ISSN: 0918-2918 Impact factor: 1.271
Figure 1.Findings of computed tomography imaging and colonoscopy. Computed tomography showed interstitial lung disease at the bottom (A) and left renal artery stenosis (B, C). Multiple ulcerations were found by colonoscopy (D).
Figure 2.Multiple calcifications in the abdominal aorta and peripheral arteries. The open arrow indicates superior mesenteric artery stenosis, and the filled arrow indicates multiple calcifications.
Figure 3.Magnetic resonance imaging of the lower limbs and pathological features of the muscle. (A) Magnetic resonance imaging demonstrated discretely granular hyperintensities on STIR images in the femoral musculature. (B) A muscle biopsy specimen revealed fibrinoid necrosis of medium-sized vessels and disruption of the elastic lamina of the vessels in the perimysium. (C) Muscle necrosis was identified in arterial distribution without inflammatory cell infiltration, which was consistent with ischemia. STIR: slow tau inversion recovery
Figure 4.Clinical course after the treatment. The patient was treated with methylprednisolone pulse therapy followed by prednisolone at 45 mg/day. He was also treated with 500 mg of monthly intravenous cyclophosphamide therapy. The proximal muscle disturbance and levels of CRP and CK were rapidly improved, although the muscle weakness in the tibiales anterior muscle remained. He showed sustained remission for two months after the initial induction therapy. PSL: prednisolone, mPSL: methylprednisolone, IVCY: intravenous cyclophosphamide, MMT: Manual Muscle Testing, TA: tibial anterior muscle, CK: creatinine kinase, CRP: C-reactive protein
Figure 5.Findings of computed tomography imaging, colonoscopy, and magnetic resonance imaging of the lower limbs after treatment. Although interstitial lung disease (A) and the stenosis of the renal artery (B, C) were not changed after the treatment, the multiple ulcerations of colon were improved (D). The discretely granular hyperintensities on STIR in femoral muscle were also improved (E). STIR: slow tau inversion recovery
Comparison between Past Literature and Our Case.
| Baseline characteristics | Our case | Ref No.10 | Ref No.11 | Ref No. 12 | Ref No.13 | Ref No.14 | Ref No.15 | Ref No.16 | Ref No.17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Case 1 | Case 2 | |||||||||
| Age | 70 | 40 | 32 | 23 | 25 | 44 | 47 | 57 | 54 | 38 |
| Gender | M | M | F | F | M | F | M | F | M | F |
| Myalgia | + | + | + | + | + | + | + | + | + | + |
| Fever | - | - | + | - | + | + | - | + | + | - |
| ESR (mm/h) | 75 | 24 | 115 | 89 | 40 | 46 | 106 | 96 | 86 | 87 |
| CRP (mg/dL) | 19.4 | NA | NA | NA | NA | NA | NA | 3.43 | 21.6 | 21.6 |
| WBC (/μL) | 15,600 | 5,000 | 12,900 | 9,300 | 16,870 | NA | 9,700 | 10,000 | 19,000 | 10,400 |
| CK (IU/L) | 1,451 | Normal | SI | SI | Normal | Normal | Normal | Normal | Normal | Normal |
| Treatment regimen | PSL 50 mg IVCY | BM 1.5 mg | PSL 60 mg | PSL 60 mg | PSL 60 mg | PSL 20 mg | PSL 60 mg | PSL 30 mg | PSL 60 mg | PSL 15 mg |
| Time to remission (day) | 7 | 7 | 1 | 5 | 5 | 7 months | 1-2 | 5 | 1 | 1 |
NA: not available, SI: slightly increased, ESR: erythrocyte sedimentation rate, CK: creatinine kinase, WBC: white blood cells, PSL: prednisolone, IVCY: intravenous cyclophosphamide